“Targeting the CB2 receptor could be a therapeutic strategy to prevent or treat diseases like Crohn’s disease [inflammation of the intestinal tract], liver cirrhosis, osteoarthritis, and atherosclerosis,” said lead study author Jürg Gertsch.

read more | digg story

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s